Bymetric
UK company intelligence
Company Active PLC

Company profile

Avacta Group PLC

UK company 04748597, incorporated on 29 April 2003.

Home | Avacta Life Sciences Limited

We develop safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer and pre|CISION platforms

Company number
04748597
Incorporated
29 Apr 2003
Companies House status
Active

Company identity

Founded / incorporated
29 April 2003

Company number 04748597

Verify at Companies House
Legal name
AVACTA GROUP PLC
Company type
PLC
Region
Unknown
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

Controls 12
Avacta Group PLC
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

8 events
25 Sep
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUZBU09PSUphZGlxemtjeA | Paper/PDF filed

Published 28 Sep 2026 23:21

21 Sep
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzU0NjAyNDY0OGFkaXF6a2N4

Published 21 Sep 2026 11:21

31 Jul
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUzNjMwMjIzMWFkaXF6a2N4

Published 31 Jul 2026 10:57

31 Jul
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUzNjI5OTgzOWFkaXF6a2N4

Published 31 Jul 2026 10:45

30 Jul
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUzNjA3ODI3NWFkaXF6a2N4

Published 30 Jul 2026 17:35

30 Jul
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUzNjA3ODAyOWFkaXF6a2N4

Published 30 Jul 2026 17:30

28 Jul
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUzNTQ1OTI1M2FkaXF6a2N4

Published 28 Jul 2026 10:05

29 Apr
2003

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2006
Funded years
2006
Age at first award
3 years

Projects

2006 Collaborative R&D Lead participant

Multispectral Analysis: Improved Tools for Process Optimisation and Formulation

1 Aug 2006 to 31 Jul 2009

Awarded
£178,837
Total cost £447,094

Awaiting Public Summary

Product types

Collaborative R&D